\begin{thebibliography}{}

\bibitem[Alagoz et~al., 2010]{alagoz2010operations}
Alagoz, O., Ayer, T., and Erenay, F.~S. (2010).
\newblock Operations research models for cancer screening.
\newblock {\em Wiley Encyclopedia of Operations Research and Management
  Science}.

\bibitem[Andrinopoulou and Rizopoulos, 2016]{andrinopoulou2016bayesian}
Andrinopoulou, E.-R. and Rizopoulos, D. (2016).
\newblock Bayesian shrinkage approach for a joint model of longitudinal and
  survival outcomes assuming different association structures.
\newblock {\em Statistics in Medicine}, 35(26):4813--4823.

\bibitem[Balasubramanian and Lagakos, 2003]{balasubramanian2003estimation}
Balasubramanian, R. and Lagakos, S.~W. (2003).
\newblock Estimation of a failure time distribution based on imperfect
  diagnostic tests.
\newblock {\em Biometrika}, 90(1):171--182.

\bibitem[Bebu and Lachin, 2017]{bebu2017optimal}
Bebu, I. and Lachin, J.~M. (2017).
\newblock Optimal screening schedules for disease progression with application
  to diabetic retinopathy.
\newblock {\em Biostatistics}, 19(1):1--13.

\bibitem[Bokhorst et~al., 2015]{bokhorst2015compliance}
Bokhorst, L.~P., Alberts, A.~R., Rannikko, A., Valdagni, R., Pickles, T.,
  Kakehi, Y., Bangma, C.~H., Roobol, M.~J., and {\relax PRIAS study group}
  (2015).
\newblock Compliance rates with the {Prostate Cancer Research International
  Active Surveillance (PRIAS)} protocol and disease reclassification in
  noncompliers.
\newblock {\em European Urology}, 68(5):814--821.

\bibitem[Brown, 2009]{brown2009assessing}
Brown, E.~R. (2009).
\newblock Assessing the association between trends in a biomarker and risk of
  event with an application in pediatric {HIV/AIDS}.
\newblock {\em The Annals of Applied Statistics}, 3(3):1163--1182.

\bibitem[Coley et~al., 2017]{coley2017prediction}
Coley, R.~Y., Zeger, S.~L., Mamawala, M., Pienta, K.~J., and Carter, H.~B.
  (2017).
\newblock Prediction of the pathologic {Gleason} score to inform a personalized
  management program for prostate cancer.
\newblock {\em European Urology}, 72(1):135--141.

\bibitem[Cook and Wong, 1994]{cook1994equivalence}
Cook, R.~D. and Wong, W.~K. (1994).
\newblock On the equivalence of constrained and compound optimal designs.
\newblock {\em Journal of the American Statistical Association},
  89(426):687--692.

\bibitem[De~Boor, 1978]{de1978practical}
De~Boor, C. (1978).
\newblock {\em A practical guide to splines}, volume~27.
\newblock Springer-Verlag New York.

\bibitem[de~Carvalho et~al., 2017a]{carvalho}
de~Carvalho, T.~M., Heijnsdijk, E.~A., and de~Koning, H.~J. (2017a).
\newblock Estimating the risks and benefits of active surveillance protocols
  for prostate cancer: a microsimulation study.
\newblock {\em BJU International}, 119(4):560--566.

\bibitem[de~Carvalho et~al., 2017b]{de2017should}
de~Carvalho, T.~M., Heijnsdijk, E.~A., and de~Koning, H.~J. (2017b).
\newblock When should active surveillance for prostate cancer stop if no
  progression is detected?
\newblock {\em The Prostate}, 77(9):962--969.

\bibitem[Eilers and Marx, 1996]{eilers1996flexible}
Eilers, P.~H. and Marx, B.~D. (1996).
\newblock Flexible smoothing with {B-splines} and penalties.
\newblock {\em Statistical Science}, 11(2):89--121.

\bibitem[Epstein et~al., 2016]{epsteinGG2014}
Epstein, J.~I., Egevad, L., Amin, M.~B., Delahunt, B., Srigley, J.~R., and
  Humphrey, P.~A. (2016).
\newblock The 2014 international society of urological pathology ({ISUP})
  consensus conference on {Gleason} grading of prostatic carcinoma.
\newblock {\em The American Journal of Surgical Pathology}, 40(2):244--252.

\bibitem[Inoue et~al., 2018]{inoue2018comparative}
Inoue, L.~Y., Lin, D.~W., Newcomb, L.~F., Leonardson, A.~S., Ankerst, D.,
  Gulati, R., Carter, H.~B., Trock, B.~J., Carroll, P.~R., Cooperberg, M.~R.,
  et~al. (2018).
\newblock Comparative analysis of biopsy upgrading in four prostate cancer
  active surveillance cohorts.
\newblock {\em Annals of Internal Medicine}, 168(1):1--9.

\bibitem[Jullion and Lambert, 2007]{jullion2007robust}
Jullion, A. and Lambert, P. (2007).
\newblock Robust specification of the roughness penalty prior distribution in
  spatially adaptive bayesian p-splines models.
\newblock {\em Computational Statistics \& Data Analysis}, 51(5):2542--2558.

\bibitem[Krist et~al., 2007]{krist2007timing}
Krist, A.~H., Jones, R.~M., Woolf, S.~H., Woessner, S.~E., Merenstein, D.,
  Kerns, J.~W., Foliaco, W., and Jackson, P. (2007).
\newblock Timing of repeat colonoscopy: disparity between guidelines and
  endoscopistsâ€™ recommendation.
\newblock {\em American Journal of Preventive Medicine}, 33(6):471--478.

\bibitem[Lang and Brezger, 2004]{lang2004bayesian}
Lang, S. and Brezger, A. (2004).
\newblock Bayesian p-splines.
\newblock {\em Journal of Computational and Graphical Statistics},
  13(1):183--212.

\bibitem[Le~Clercq et~al., 2015]{LeClercq2015325}
Le~Clercq, C., Winkens, B., Bakker, C., Keulen, E., Beets, G., Masclee, A., and
  Sanduleanu, S. (2015).
\newblock Metachronous colorectal cancers result from missed lesions and
  non-compliance with surveillance.
\newblock {\em Gastrointestinal Endoscopy}, 82(2):325--333.e2.

\bibitem[Loeb et~al., 2014a]{loeb2014overdiagnosis}
Loeb, S., Bjurlin, M.~A., Nicholson, J., Tammela, T.~L., Penson, D.~F., Carter,
  H.~B., Carroll, P., and Etzioni, R. (2014a).
\newblock Overdiagnosis and overtreatment of prostate cancer.
\newblock {\em European Urology}, 65(6):1046--1055.

\bibitem[Loeb et~al., 2014b]{loeb2014heterogeneity}
Loeb, S., Carter, H.~B., Schwartz, M., Fagerlin, A., Braithwaite, R.~S., and
  Lepor, H. (2014b).
\newblock Heterogeneity in active surveillance protocols worldwide.
\newblock {\em Reviews in Urology}, 16(4):202--203.

\bibitem[Loeb et~al., 2013]{loeb2013systematic}
Loeb, S., Vellekoop, A., Ahmed, H.~U., Catto, J., Emberton, M., Nam, R.,
  Rosario, D.~J., Scattoni, V., and Lotan, Y. (2013).
\newblock Systematic review of complications of prostate biopsy.
\newblock {\em European Urology}, 64(6):876--892.

\bibitem[McCulloch and Neuhaus, 2005]{mcculloch2005generalized}
McCulloch, C.~E. and Neuhaus, J.~M. (2005).
\newblock Generalized linear mixed models.
\newblock {\em Encyclopedia of Biostatistics}, 4.

\bibitem[McWilliams et~al., 2008]{mcwilliams2008surveillance}
McWilliams, T.~J., Williams, T.~J., Whitford, H.~M., and Snell, G.~I. (2008).
\newblock Surveillance bronchoscopy in lung transplant recipients: risk versus
  benefit.
\newblock {\em The Journal of Heart and Lung Transplantation},
  27(11):1203--1209.

\bibitem[Rizopoulos, 2012]{rizopoulos2012joint}
Rizopoulos, D. (2012).
\newblock {\em Joint Models for Longitudinal and Time-to-Event Data: With
  Applications in R}.
\newblock CRC Press.

\bibitem[Rizopoulos, 2016]{rizopoulosJMbayes}
Rizopoulos, D. (2016).
\newblock The {R} package {JMbayes} for fitting joint models for longitudinal
  and time-to-event data using {MCMC}.
\newblock {\em Journal of Statistical Software}, 72(7):1--46.

\bibitem[Rizopoulos et~al., 2017]{landmarking2017}
Rizopoulos, D., Molenberghs, G., and Lesaffre, E.~M. (2017).
\newblock Dynamic predictions with time-dependent covariates in survival
  analysis using joint modeling and landmarking.
\newblock {\em Biometrical Journal}, 59(6):1261--1276.

\bibitem[Rizopoulos et~al., 2015]{rizopoulos2015personalized}
Rizopoulos, D., Taylor, J.~M., Van~Rosmalen, J., Steyerberg, E.~W., and
  Takkenberg, J.~J. (2015).
\newblock Personalized screening intervals for biomarkers using joint models
  for longitudinal and survival data.
\newblock {\em Biostatistics}, 17(1):149--164.

\bibitem[Sassi, 2006]{sassi2006calculating}
Sassi, F. (2006).
\newblock Calculating {QALYs}, comparing {QALY} and {DALY} calculations.
\newblock {\em Health Policy and Planning}, 21(5):402--408.

\bibitem[Steimle and Denton, 2017]{steimle2017markov}
Steimle, L.~N. and Denton, B.~T. (2017).
\newblock Markov decision processes for screening and treatment of chronic
  diseases.
\newblock In {\em Markov Decision Processes in Practice}, pages 189--222.
  Springer.

\bibitem[Taylor et~al., 2013]{taylor2013real}
Taylor, J.~M., Park, Y., Ankerst, D.~P., Proust-Lima, C., Williams, S., Kestin,
  L., Bae, K., Pickles, T., and Sandler, H. (2013).
\newblock Real-time individual predictions of prostate cancer recurrence using
  joint models.
\newblock {\em Biometrics}, 69(1):206--213.

\bibitem[Tomer et~al., 2020]{tomer2020webapp}
Tomer, A., Nieboer, D., Roobol, M.~J., Bjartell, A., Steyerberg, E.~W.,
  Rizopoulos, D., and et~al. (2020).
\newblock Risk of upgrading based personalized biopsy schedules for prostate
  cancer active surveillance patients.
\newblock {\em -}, manuscript submitted to British Journal of Urology
  International(-):--.

\bibitem[Tomer et~al., 2019a]{tomer2019personalizedbiometrics}
Tomer, A., Nieboer, D., Roobol, M.~J., Steyerberg, E.~W., and Rizopoulos, D.
  (2019a).
\newblock Personalized schedules for surveillance of low-risk prostate cancer
  patients.
\newblock {\em Biometrics}, 75(1):153--162.

\bibitem[Tomer et~al., 2019b]{tomer2019personalized}
Tomer, A., Rizopoulos, D., Nieboer, D., Drost, F.-J., Roobol, M.~J., and
  Steyerberg, E.~W. (2019b).
\newblock Personalized decision making for biopsies in prostate cancer active
  surveillance programs.
\newblock {\em Medical Decision Making}, 39(5):499--508.

\bibitem[Torre et~al., 2015]{GlobalCancerStats2012}
Torre, L.~A., Bray, F., Siegel, R.~L., Ferlay, J., Lortet-Tieulent, J., and
  Jemal, A. (2015).
\newblock Global cancer statistics, 2012.
\newblock {\em CA: A Cancer Journal for Clinicians}, 65(2):87--108.

\bibitem[Tsiatis and Davidian, 2004]{tsiatis2004joint}
Tsiatis, A.~A. and Davidian, M. (2004).
\newblock Joint modeling of longitudinal and time-to-event data: an overview.
\newblock {\em Statistica Sinica}, 14(3):809--834.

\bibitem[Turnbull, 1976]{turnbull1976empirical}
Turnbull, B.~W. (1976).
\newblock The empirical distribution function with arbitrarily grouped,
  censored and truncated data.
\newblock {\em Journal of the Royal Statistical Society. Series B
  (Methodological)}, 38(3):290--295.

\bibitem[Vickers and Elkin, 2006]{vickers2006decision}
Vickers, A.~J. and Elkin, E.~B. (2006).
\newblock Decision curve analysis: a novel method for evaluating prediction
  models.
\newblock {\em Medical Decision Making}, 26(6):565--574.

\bibitem[Wang et~al., 2019]{wang2019learning}
Wang, Y., Zhao, Y.-Q., and Zheng, Y. (2019).
\newblock Learning-based biomarker-assisted rules for optimized clinical
  benefit under a risk-constraint.
\newblock {\em Biometrics}.

\bibitem[Weusten et~al., 2017]{weusten2017endoscopic}
Weusten, B., Bisschops, R., Coron, E., Dinis-Ribeiro, M., Dumonceau, J.-M.,
  Esteban, J.-M., Hassan, C., Pech, O., Repici, A., Bergman, J., et~al. (2017).
\newblock Endoscopic management of {Barrett's} esophagus: {European Society of
  Gastrointestinal Endoscopy (ESGE)} position statement.
\newblock {\em Endoscopy}, 49(02):191--198.

\bibitem[WHO et~al., 2014]{world2014global}
WHO, W. H.~O. et~al. (2014).
\newblock {\em Global status report on noncommunicable diseases 2014}.
\newblock Number WHO/NMH/NVI/15.1. World Health Organization.

\end{thebibliography}
